Hallucinations and sleep disorders in PD: Ten-year prospective longitudinal study

Neurology

Volumn 75, Issue 20, 2010, Pages 1773-1779

  Goetz, Christopher G ^a   Ouyang, Bichun ^a   Negron, Alice ^a   Stebbins, Glenn T ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HALLUCINATION; HUMAN; INTROSPECTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NIGHTMARE; PARKINSON DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SLEEP DISORDER; VIVID DREAM;

EID: 78649987263     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181fd6158     Document Type: Article

References (17)

1. Fénelon G, Mahieux F, Huon R, Ziégler M. Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors. Brain 2000;123:733-745.
2. Goetz CG, Stebbins GT. Risk factors for nursing home placement in advanced Parkinson's disease. Neurology 1993;43:2227-2229.
3. Goetz CG, Stebbins GT. Mortality and hallucination in nursing home patients with advanced Parkinson's disease. Neurology 1995;45:669-671.
4. Scaravilli T, Gasparoli E, Rinaldi F. Health-related quality of life and sleep disorders in Parkinson's disease. Neurol Sci 2003;24:209-210.
5. Goetz CG, Wuu J, Curgian LM, Leurgans S. Hallucinations and sleep disorders in PD: Six year prospective longitudinal study. Neurology 2005;64:81-86.
6. Fahn S, Elton RL, UPDRS program members. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, eds. Recent Developments in Parkinson's Disease, vol. 2. Florham Park, NJ: Macmillan Healthcare Information; 1987:153-163.
7. Goetz CG, Leurgans S, Pappert EJ, Raman R, Stemer AB. Prospective longitudinal assessment of hallucinations in Parkinson's disease. Neurology 2001;57:2078-2082.
8. Buysse DJ, Reynolds CF, Monk TH, Berman SR. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res 1989;28: 193-213.
9. Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
10. Zeger SL, Liang K-Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-130.
11. SAS/STAT User's Guide, version 8. Cary, NC: SAS Institute Inc.; 1999.
12. Comella CL, Tanner CM, Ristanovic RK. Polysomnographic sleep measures in Parkinson's disease in patients with treatment-induced hallucinations. Ann Neurol 1993; 34:710-714.
13. Arnulf I, Bonnet AM, Damier P, Bejjani BP. Hallucinations, REM sleep and Parkinson's disease: A medical hypothesis. Neurology 2000;55:281-288.
14. Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society UPDRS Revision Task Force. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Mov Disord 2008;23:2129-2170.
15. Forsaa EB, Larsen JP, Wentzel-Larsen T, et al. A 12-year population-based study of psychosis in Parkinson disease. Arch Neurol 2010;67:996-1001.
16. Holroyd S, Currie L, Wooten GF. Prospective study of hallucinations and delusions in Parkinson's disease. J Neurol Neurosurg Psychiatry 2001;70:734-738.
17. Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG. The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years. Mov Disord 2008;23:837-844.